KP ST258 Clade 2 isolates linked to increased virulence in observational and mouse studies
This study combined an observational clinical review and a preclinical mouse model to investigate virulence differences between Klebsiella pneumoniae ST258 Clade 1 and Clade 2 isolates. The clinical component analyzed 172 isolates from patients at a single medical center, while the mouse model compared infection outcomes. Patients infected with Clade 2 isolates were more acutely ill and had fewer comorbidities than those with Clade 1, though exact numbers and statistical significance were not reported. In laboratory tests, Clade 2 isolates were more resistant to killing by human serum and bound more complement protein C3 than Clade 1 isolates.
In the mouse model, infection with a Clade 2 isolate led to increased bacterial dissemination from the lungs to the liver and spleen compared to Clade 1, with this effect requiring an intact capsule locus. Dissemination was associated with decreased macrophage uptake of the Clade 2 isolate. However, mouse serum was unable to kill isolates of either clade, highlighting a divergence from human serum responses. Safety and tolerability data were not reported in the study.
Key limitations include differences in host response between mice and humans, and the use of mouse models may not fully capture defenses against multidrug-resistant KP infection. The practice relevance underscores the importance of capsule composition in KP ST258 virulence and identifies a potential role for complement-targeting immunotherapeutics, but mechanisms appear to differ between species. These findings should be viewed as preliminary due to the observational design and lack of causal evidence.